Completed
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)
NCT00989612
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Fukuoka, Japan
- GSK Investigational Site Tokyo, Japan